Karnataka collects 32.68 lakh litres of used oil; orders stricter checks on reuse, fortification
All cooking oil manufacturing units have now been directed to fortify their products with Vitamins A and D, maintain strict hygiene standards, and get their oils tested every six months. Proper labelling in line with FSSAI norms has also been made mandatory.
The move, aimed at improving public health and preventing the unsafe reuse of oil, came during a state-wide video conference chaired by the Food Safety Commissioner. Officials reviewed the functioning of the Repurpose Used Cooking Oil (RUCO) initiative and flagged the need for more responsible handling of used oil.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
4 hours ago
- Hindustan Times
Gastroenterologist shares 7 common mistakes people make while cooking in air fryer: ‘Always clean the tray and use…'
Air fryers have become a go-to kitchen appliance for those looking to cut down on oil without compromising on taste. But while they promise healthier meals, many people are unknowingly making mistakes that could defeat the purpose. Avoid these common air fryer mistakes for healthier cooking.(Freepik) Dr Saurabh Sethi, MD, MPH, board-certified gastroenterologist, hepatologist, and interventional endoscopist trained at AIIMS, Harvard and Stanford, shared in his July 31 Instagram post 7 common air fryer blunders that might be doing your health more harm than good. (Also read: Gastroenterologist says 'these 9 simple drinks can support natural liver detox' without the need for fad diets ) 1. Air frying is automatically healthy Air frying does reduce oil use, but if you're still loading up on ultra-processed frozen snacks or cooking with inflammatory refined seed oils, your gut isn't benefiting as much as you think. 2. You don't need oil at all A little healthy fat like avocado oil or ghee can actually help your body absorb fat-soluble vitamins such as A, D, E, and K. Just steer clear of refined seed oils, which are high in omega-6s and may contribute to inflammation when overused. 3. Any veggie works great Not quite. Leafy greens and cruciferous vegetables like broccoli can burn quickly in an air fryer. To avoid charring, which creates inflammatory compounds, use a light coating of oil and line the tray with parchment paper or a silicone liner. 4. Reusing the same oil is fine Reheating old oil at high temperatures leads to oxidised fats, which create harmful byproducts that your gut and liver won't thank you for. Always clean the tray and use fresh oil. 5. Any liner works for air frying The safest options are food-grade silicone liners (BPA-free and FDA-approved), which are reusable, free of PFAS and microplastics, heat-safe up to 480 degrees Farenhiets, and perforated for airflow. Also acceptable: unbleached, perforated parchment paper, just make sure it's free of wax or chlorine. 6. Season after air frying Actually, spices like turmeric, garlic, cumin, and paprika release more antioxidants when cooked. Seasoning before air frying means more flavour and a boost of gut-friendly polyphenols. 7. All air fryers are the same They're not. Some models have Teflon (PTFE)-coated baskets, which can degrade at high heat. Instead, opt for air fryers with ceramic-coated or stainless steel interiors; they're safer and tend to last longer. Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.
Business Standard
5 hours ago
- Business Standard
Health and Wellness Entrepreneur Sak Narwal Talks Oral Peptides - A Simpler Path to Metabolic Wellness
PNN New Delhi [India], August 1: Sak Narwal is a prominent health and wellness entrepreneur, recognized as a global wellness ambassador and a significant voice in the health and wellness industry. He is the CEO and founder of eSensorem, a metabolic health device and platform delivering continuous, non-invasive health insights as a path to proactive, preventative wellness. His work focuses on making innovative health solutions, particularly in metabolic wellness, more accessible and convenient for the general population, which is why he is now highlighting oral peptides as a groundbreaking advancement. Narwal highlights oral peptides, particularly Deglusterol in ProGsterol, as a breakthrough in metabolic wellness. This innovative approach aims to simplify daily metabolic health management, offering benefits like hunger control, glucose regulation, and enhanced fat utilization without injections. Narwal emphasizes making healthier options more convenient for the general population, a goal oral peptides are poised to achieve. Metabolic health, encompassing food breakdown, blood sugar maintenance, and energy storage, has traditionally relied on often inconvenient injectable therapies and oral medications with side effects. However, advancements in delivery systems are changing this, leveraging peptides' role as potent body messengers and cellular communicators. ProGsterol, containing the synthetic peptide Deglusterol, marks a significant milestone as the world's first synthetic peptide to receive NDI (New Dietary Ingredient) approval from the U.S. FDA. As Narwal explains: 'Deglusterol is designed to address common metabolic disorders like obesity and Type 2 Diabetes Mellitus. Its primary function is to enhance insulin sensitivity, helping the body better manage glucose levels. Furthermore, Deglusterol shows potential in mitigating fatty liver disease, particularly non-alcoholic fatty liver disease (NAFLD), which is a rising concern linked to obesity. ProGsterol, with Deglusterol inside, is considered a key solution for metabolic syndrome, impacting the central nervous system, heart/blood vessels, pancreatic islets, liver, ovary, and adipose tissue.' The core benefits of oral peptides like Deglusterol include: * Appetite and Satiety: Some of the peptides leave one feeling quite full and reduce appetites. They do so by stimulating the gut in a way that makes the brain realize that it is time to stop eating; hormones are released which makes it easy to adhere to a healthy diet. * Balanced Blood Sugar: Deglusterol increases adiponectin levels, boosts insulin receptor sensitivity, activates AMPK, and reduces inflammatory markers, leading to better glucose management. Clinical trials demonstrate significant improvements in fasting blood glucose, HbA1C, and HOMA-IR in Type II Diabetes and pre-diabetes patients. * Fat Utilization: These peptides help the body more effectively use fat for energy, supporting weight loss through enhanced fat metabolism and thermogenesis. It has been observed to lead to body weight loss and protect against liver damage in DIO NAFLD animal models. Deglusterol has shown efficacy in weight control and anti-obesity effects in animal models and human clinical studies, improving metrics like Waist-Hip Ratio (WHR), body weight, and BMI. It also inhibits fat accumulation and promotes fat breakdown at a cellular level. Overcoming digestive enzyme breakdown, researchers have developed special coatings, helper molecules, and tiny capsules for successful oral delivery. Narwal states, "While there's many supplements and injectables on the market for managing metabolic health, accessibility, efficacy and side-effects are all major barriers for consumers. Oral peptides bypass the barriers, providing a more affordable, safe, and easy to take alternative that is accessible to the people who truly need it. This is the change that the health and wellness industry has been waiting for." A critical advantage of ProGsterol over many existing Type 2 Diabetes medications is its favorable safety profile. Clinical trials have reported no observed hypoglycemia or any other side effects in consumers. It does not cause hypoglycemia, gastrointestinal side effects, or sexual dysfunction. Furthermore, it is reported to be safe for individuals with cardiovascular or renal disorders, with no cardiovascular side effects reported. Being a peptide product made of amino acids, it is designed to be compatible with the body and free of chemical drug side effects. This distinguishes ProGsterol, as while other oral medications like Metformin exist, they can come with a range of side effects. Significantly, recent research suggests that Metformin can even blunt or inhibit exercise-induced improvements in insulin sensitivity and cardiorespiratory fitness, and may reduce gains in lean muscle mass, which can be a major drawback for athletes seeking to optimize their performance and physical adaptations to training. While Narwal maintains that "there is not yet a magic pill", ProGsterol's promising clinical outcomes and superior safety profile suggest it is the most advanced "pill-based method of keeping our metabolism active" that integrates seamlessly into daily life without injections, inconvenience, or discomfort. This oral peptide could empower millions to better manage their metabolic health
NDTV
5 hours ago
- NDTV
US FDA Vaccine Chief Vinay Prasad Leaves Agency 3 Months After Appointment
Washington: The Food and Drug Administration's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of biotech executives, patient groups and conservative allies of President Donald Trump. Dr. Vinay Prasad 'did not want to be a distraction' and was stepping down from his role as the FDA's top vaccine regulator 'to spend more time with his family,' a spokesperson for the Department of Health and Human Services said in a statement late Tuesday. Two people familiar with the situation told The Associated Press that Prasad was ousted following several recent controversies. They spoke on condition of anonymity to discuss internal personnel matters. Prasad did not immediately respond to requests for comment Wednesday morning. FDA's drug center director, Dr. George Tidmarsh, will take over Prasad's job in an acting role, according to an agency email shared with the AP. Tidmarsh started at the FDA last week after a decades-long career as a pharmaceutical executive and adjunct professor. Prasad joined the FDA in May from the University of California San Francisco, where he frequently criticized the FDA's approach to drug approvals and COVID-19 vaccines. His contrarian approach appeared to match that of his boss FDA Commissioner Marty Makary, who repeatedly praised Prasad's work and intellect. But in recent weeks Prasad became a target of right-wing activists, including Laura Loomer, who flagged Prasad's past statements criticizing Trump and praising liberal independent Senator Bernie Sanders. 'How did this Trump-hating Bernie Bro get into the Trump admin???' Loomer posted on X last week. Trump previously fired several national security officials a day after Loomer raised concerns about their loyalty. Prasad also attracted scrutiny for his handling of a recent safety issue surrounding the only approved gene therapy for Duchenne's muscular dystrophy. Under his direction, shipments of the therapy were briefly halted after a series of patient deaths, then resumed late Monday following vocal pushback from families of boys with the fatal muscle-wasting disorder. Prasad has long been skeptical of the therapy and other muscular dystrophy drugs sold by the drugmaker, Sarepta Therapeutics. As an academic, Prasad gained prominence by attacking the FDA for being too lenient in its standards for approving cancer drugs and other new therapies. That approach is at odds with Trump's Republican supporters, who generally favor speedier approvals and unfettered access to experimental treatments. During Trump's first term he signed the ' Right to Try ' law, a largely symbolic piece of legislation that won popular support from conservatives seeking to give terminal patients expanded access to unproven drugs. Prasad's decision to pause Sarepta's therapy was criticized last week by a columnist and the editorial board of The Wall Street Journal. Separately, Prasad's division issued three rejection letters this month to small biotech firms seeking approval for new gene therapies. Those drugs have been vigorously embraced by many of the anti-abortion groups in Trump's base for their potential to address intractable diseases that sometimes lead parents to terminate pregnancies. Prasad's predecessor in at FDA, Dr. Peter Marks, oversaw a dramatic rise in approvals for new gene therapies, which aim to treat or prevent disease by replacing or modifying a portion of patients' genetic code. Prasad has been an outspoken critic of Marks' leadership at FDA, which included overseeing the approval of the first COVID vaccines and therapies.
